Sorbent Therapeutics is a private biopharmaceutical company focused on the development of adaptable non-absorbed polymeric drugs to satisfy unmet clinical needs in large markets such as Congestive Heart Failure (CHF), Chronic Kidney Disease (CKD), End Stage Renal Disease (ESRD), and Hypertension. The array of customized compounds under development in our pipeline are all based on CLP's robust platform, which can be tailored to sequester or contribute targeted ions and/or fluid.